CCS
CC icon

Concentric Capital Strategies’s Chemours CC Stock Holding History

Concentric Capital Strategies’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,585
Closed -$233K – 329
2026
Q1 		$233K Buy
+10,585
New +$184K 0.02% 295
2025
Q4 		– Sell
-127,026
Closed -$2.01M – 267
2025
Q3 		$2.01M Buy
+127,026
New +$1.84M 0.09% 181
2024
Q2 		– Sell
-111,995
Closed -$2.93M – 300
2024
Q1 		$2.94M Buy
111,995
+72,806
+186% +$2.07M 0.17% 143
2023
Q4 		$1.24M Buy
+39,189
New +$1.06M 0.14% 127
2023
Q2 		– Sell
-27,000
Closed -$808K – 152
2023
Q1 		$808K Buy
+27,000
New +$889K 0.26% 95

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Concentric Capital Strategies's CC Position: Q2 2026 in Review

Concentric Capital Strategies sold out of Chemours (CC) in Q2 2026, closing a stake of 10,585 shares — an estimated $233K sold.

Concentric Capital Strategies first reported a position in CC in Q1 2023 and held it in 5 quarters. The position peaked at $2.94M in Q1 2024. 471 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Concentric Capital Strategies reported no remaining Chemours position as of Q2 2026 after selling out during the quarter.
  • Concentric Capital Strategies sold 10,585 Chemours shares in Q2 2026, an estimated $233K.
  • Concentric Capital Strategies first reported a position in Chemours in Q1 2023 and held it in 5 quarters.
  • Concentric Capital Strategies's Chemours position peaked at $2.94M in Q1 2024.
  • 471 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.